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Abstract
Background: Aneuploidy has been acknowledged as a major source of genomic instability in cancer, and it is
often considered the result of chromosome segregation errors including those caused by defects in genes
controlling the mitotic spindle assembly, centrosome duplication and cell-cycle checkpoints. Aneuploidy and
chromosomal instability has been also correlated with epigenetic alteration, however the molecular basis of this
correlation is poorly understood.
Results: To address the functional connection existing between epigenetic changes and aneuploidy, we used
RNA-interference to silence the DNMT1 gene, encoding for a highly conserved member of the DNA methyl-
transferases. DNMT1 depletion slowed down proliferation of near-diploid human tumor cells (HCT116) and
triggered G1 arrest in primary human fibroblasts (IMR90), by inducing p53 stabilization and, in turn, p21waf1
transactivation. Remarkably, p53 increase was not caused by DNA damage and was not observed after p14-ARF
post-transcriptional silencing. Interestingly, DNMT1 silenced cells with p53 or p14-ARF depleted did not arrest in G1
but, instead, underwent DNA hypomethylation and became aneuploid.
Conclusion: Our results suggest that DNMT1 depletion triggers a p14ARF/p53 dependent cell cycle arrest to
counteract the aneuploidy induced by changes in DNA methylation.
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Background
Genomic instability is a characteristic of the majority of
human tumors and is considered a driving force for
tumorigenesis. Various forms of genome instability have
been described and characterized by an increased rate of
a number of different genetic alterations [1,2]. Most
cancers show a form that is called chromosomal
instability (CIN), which refers to the high rate of numer-
ical and structural chromosome changes found in cancer
cells compared to normal cells. Numerical CIN is char-
acterized by gains and losses of whole chromosomes
(aneuploidy) during cell proliferation. Mutations in
genes encoding mitotic regulators [3] and in genes con-
trolling centrosome numbers and tumor suppressors
[4-7] have been suggested as molecular defects underly-
ing aneuploidy.
Nevertheless, correct chromosome structure and func-
tion may play a role in the stabilization and normal
functioning of chromosome segregation. Indeed, it is
now accepted that gene expression and chromosome
organization are mainly affected by epigenetic marks
and may be implicated in the normal chromosome seg-
regation process. Thus, epigenetic alterations should be
considered as a cause of aneuploid cells generation [8].
In fact, imbalance in cytosine methylation of CpG
islands is a recurrent event in human sporadic cancers.
Hypomethylation and hypermethylation occur at specific
but different sites within the cancer cell genome and
can precede malignancy. Global genome hypomethyla-
tion in breast, ovarian, cervical and brain tumors
increases with increasing malignancy [9]. However, it is
still object of investigation the mechanism(s) that
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correlates hypomethylation with tumor initiation-pro-
gression. Several hypotheses have been proposed,
including chromosomal instability induced by hypo-
methylation of pericentromeric regions [10].
DNA-methyltransferases (DNMTs) - namely DNMT1,
DNMT3a and DNMT3b in humans - are directly
involved in DNA methylation. DNMT1 differs from the
other two human DNA methylases, DNMT3a and
DNMT3b, mainly because it is unable to methylate
DNA with both strands unmethylated (de novo methyla-
tion) [11]. DNMT1 is able to restore DNA methylation
patterns during S-phase of the cell cycle and it has been
recently implicated in genomic stability [12]. In addition,
DNMT1 was found deregulated in different human
tumors suggesting its involvement in tumor initiation/
progression. To investigate DNMT1 implication in the
generation of chromosomal instability (aneuploidy), we
evaluated the effects of its depletion by RNA interfer-
ence in primary human fibroblasts (IMR90) and in near
diploid human tumor cells (HCT116). DNMT1 post-
transcriptional silencing in IMR90 cells resulted in G1
arrest, associated with increased expression of p21WAF1-
Cip1 and p53 stabilization. p53 stabilization was not
caused by DNA damage. Simultaneous p14ARF and
DNMT1 transcriptional silencing in IMR90 cells did not
result in p53 stabilization and G1 arrest. Accordingly,
HCT116 cells, that are p14ARF-null [13] did not arrest
in response to DNMT1-depletion. Thus, overriding the
G1 arrest after DNMT1-depletion resulted in global
DNA hypomethylation and aneuploidy.
Our results suggest that DNMT1 deficiency induces
different outcomes depending on the genetic back-
ground of the cells. In IMR90 cells DNMT1 depletion
resulted primarily in cell cycle arrest, while in HCT116
tumor cells, missing p14ARF, induced aneuploidy, prob-
ably affecting the correct chromosomal segregation by
altering the DNA methylation pattern.
Results
DNMT1 depletion induces growth delay in HCT116 cells
and G1 arrest in IMR90 cells
In order to deplete transiently DNMT1 in IMR90 and
HCT116 cells, we used an siRNA (siDNMT1) targeting
a portion of the DNMT1 transcript, previously shown to
silence DNMT1 specifically [14]. As a control it was
used an siRNA targeting the green fluorescent protein
(siGFP). Microscopy observation of both cell lines
revealed that the control siRNA did not affect cell mor-
phology/viability in comparison with untreated cells. On
the contrary transfection with siDNMT1 induced
changes in the morphology and proliferation of cells
(Figure 1A). By counting cells every 24 hours following
siRNAs transfection, we found that IMR90-siDNMT1
cell numbers did not increase during the first 72 hours
of silencing, and cells resumed proliferation at 144
hours post-transfection (Figure 1B). Instead, HCT-
siDNMT1 cells do proliferate, even if more slowly than
control cells during the 72 hours following transfection
of siDNMT1 (Figure 1B). On the contrary, we did not
observe significative differences in cell proliferation after
control siRNA (siGFP) transfection. Real time RT-PCR
showed reduction of DNMT1 gene expression levels
(about 80%) after siDNMT1 transfection in both cellular
types (Figure 1C). The experiment was run by using
cDNA generated from mRNA extracted at 72 hours
post-transfection from both cell types. To determine
whether mRNA decreased levels correlated with
DNMT1 protein reduction, protein were extracted from
cells transfected with siDNMT1 and from control cells.
Western blotting for DNMT1 revealed a large decrease
of DNMT1 protein in IMR90 cells and only its partial
reduction in HCT116 cells (Figure 1D).
It is conceivable that DNMT1 depletion, causing
defects in DNA methylation, will be sensed as a stress
signal eliciting a cell cycle response (arrest/delay) in the
cell. To address this further, we did cytofluorimetric
analyses of IMR90-siDNMT1 and HCT-siDNMT1 cells
at 72 hours post-transfection to compare them with
control cells (siGFP transfected). To assess the number
of cells actively replicating DNA (S-phase cells), cells
were labeled with BromodeoxiUridine (BrdU) that is
incorporated during DNA synthesis, and were then ana-
lyzed simultaneously for BrdU incorporation and propi-
dium iodide (PI) staining. Cytofluorimetric analyses
showed a large decrease in the number of IMR90-
siDNMT1 S-phase cells (BrdU positive) and accumula-
tion of the cells in the G1-phase (Figure 1E) indicative
of a G1 arrest. On the contrary, HCT-siDNMT1 cells
did not arrest in G1 but they accumulated in S-phase
delaying the G2/M phase entry (Figure 1E). Collectively,
these findings highlight a different response to DNMT1
depletion of IMR90 human fibroblasts versus HCT116
cells.
IMR90 cells sense DNMT1 decrease and activate a p53-
controlled pathway
Since DNMT1 is part of the replication fork [15], we
reasoned that DNMT1 depletion could activate a path-
way similar to that triggered by DNA replication stress,
leading to inhibition of DNA replication origin firing
and thus inducing cell cycle arrest (Figure 1E). To this
aim we examined the effect of DNMT1 post-transcrip-
tional silencing on p21WAF1-Cip1 expression that is
responsible for G1 arrest induced by DNA damage. Real
time RT-PCR revealed a strong increase of p21WAF1-Cip1
transcript in IMR90-siDNMT1 cells in comparison to
control cells (Figure 2A). These results were confirmed
by the increase of both p21WAF1-Cip1, and p53 proteins
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(Figure 2B, C). We observed also increase of p53 tran-
script levels that was probably caused by the positive
feedback of p53 protein on its own promoter, as
reported previously [16] (Figure 2A). On the contrary,
we did not observe increase of p21WAF1-Cip1 and p53
protein levels in HCT-siDNMT1 cells (Figure 2A, C).
Moreover, at 144 hours after DNMT1 silencing, when
IMR90 cells restart proliferation, we found a reduced
amount of the p53 protein (Figure 2C).
These results suggest that p53 might be involved in
the G1 arrest observed in IMR90-siDNMT1 cells by
transactivating p21WAF1-Cip1. To investigate this further,
IMR90 cells were simultaneously transfected with siR-
NAs specifically targeting DNMT1 and p53. Real time
Figure 1 DNMT1-depletion caused cell growth delay. A) Morphology of IMR90 and HCT116 cells 24 and 72 hours post-transfection of
siDNMT1 or siGFP. There are only slight differences between cells untreated (wt) and transfected with control siRNA (siGFP), on the contrary the
treatment with siDNMT1 altered cell density/dish. B) Pictures and histogram showing the effects of siRNAs targeting DNMT1 and controls (wt
and siGFP) in IMR90 and HCT116 cells on proliferation. Human fibroblasts slowed down proliferation in comparison to control cells at 72 h;
however they resumed proliferation at 144 h. HCT116 cells growth was less affected by DNMT1 silencing. C) Real Time RT-PCR analysis of IMR90
and HCT116 cells showing decrease of DNMT1 transcriptional reduction after 72 hours from transfection of siRNAs targeting DNMT1. D) Western
Blot showing the reduction of DNMT1 protein in both IMR90 and HCT116 cells treated with siDNMT1, consistent with Real Time RT-PCR results
(see Additional file 1 for the densitometric analysis) E) Cytofluorimetric profiles of IMR90 and HCT116 cells pulsed with BrdU for 1 h, and stained
with anti-BrdU antibody FITC-conjugated and propidium iodide. Following DNMT1 silencing IMR90 cells arrested in G1, while HCT116 cells
slightly accumulated in S phase.
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RT-PCR and Western blot analyses confirmed reduced
expression of DNMT1 and p53 in these silenced cells in
comparison to control cells (Figure 2D, E). In addition,
western blotting showed p21WAF1-Cip1 reduction in these
double silenced cells (Figure 2E), indicating its correla-
tion with p53 depletion.
At 72 hours post-transfection the number of double
transfected cells was similar to that of control cells (Figure
2F top panel). By counting cells every 24 hours, we noticed
that cells proliferate as the control cells (Figure 2F central
panel). Cytofluorimetric analyses showed also that
siDNMT1/p53 cells progressed normally in the cell cycle,
while IMR90-siDNMT1 arrested in G1 (Figures 2F, 1E).
These findings suggest that p53 reduction allowed an
incorrect cell cycle progression of DNMT1-depleted cells.
To exclude the presence of DNA damage following
DNMT1 depletion we monitored the amount of phos-
phorylated H2A.X protein by immunofluorescence
microscopy. Phosphorylated H2A.X (gH2AX) is a modi-
fied histone that accumulates at DNA double-stranded
breaks and functions to recruit DNA repair protein. We
observed a small difference of gH2AX positive nuclei
between control and silenced cells (IMR90-siDNMT1
and HCT-siDNMT1) (Figure 3). On the contrary, Adria-
mycin treatment increased the percentage of gH2AX
positive cells (Figure 3, 60% of observed nuclei) as well
the p53 protein level (Figure 2C) indicating that the
DNA damage pathway is functional under the our
experimental conditions. This result suggests that the
cell response pathway activated by DNMT1 depletion, is
not induced by DNA damage.
P14ARF is involved in a cell response to DNMT1
depletion
The difference between the behaviour of IMR90 and
HCT116 cells in response to DNMT1 knock-down
seems to be due to a specific cell stress pathway that is
missing in HCT116 cells. Since p14ARF, known to sta-
bilize p53 by sequestering MDM2, is not functioning in
HCT116 [13], we checked the involvement of p14ARF, in
Figure 2 p53 post-transcriptional silencing abrogates the G1 arrest after DNMT1 depletion. A) Real time RT-PCR and (B, C) Western Blot
analysis revealed a strong increase of p21waf1-Cip1 and p53 protein levels in IMR90 cells and not in HCT116 cells at 72 hours siDNMT1 post-
transfection. At 144 hours p53 level was reduced. Cells treated with adriamicyn to induce DNA damage were used to assess the functionality of
the p53 pathway. D) Real time RT-PCR and detection of p53 and DNMT1 protein levels by WB (E) in siDNMT1/p53 (72 h) and control IMR90 cells.
Summary graphs illustrating differences in p21waf1-Cip1 and p53 protein levels (see Additional files 2, 3, and 4 for the relative densitometric
analyses). Data are expressed related to control cells following normalization with b-tubulin. F) Top panels: IMR90-ctrl and IMR90-siDNMT1/p53
cells pictures at 72 hours post-transfection showing that cell density/dish in IMR90-siDNMT1/p53 cells is comparable to that of IMR90-ctrl cells.
Central panels: cytofluorimetric profiles showing no significative differences in cell cycle distribution of control and IMR90-siDNMT1/p53 cells.
Bottom panel: histogram showing IMR90 siDNMT1/p53 cells proliferation in comparison to control and sip53 cells.
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the cellular response to DNMT1 depletion. To this aim
we looked at p14ARF transcriptional level by Real time
RT-PCR in IMR90-siDNMT1 cells and we did not found
significative differences in comparison to control cells
(Figure 4A). Nevertheless, to investigate further on
p14ARF potential involvement in p53 activation/stabili-
zation after DNMT1 depletion, we performed a double
siRNAs transfection with siDNMT1 and sip14ARF in
IMR90 cells (Figure 4A). Interestingly, using Real-time
RT-PCR we observed that p21WAF1-Cip1 transcripts were
not increased (Figure 4B) as observed after single post-
transcriptional silencing of DNMT1 (Figure 2A). This
result suggested that the p53-dependent pathway trigger-
ing the G1 arrest was not activated in these cells. In fact,
by counting cells every 24 hours from siRNA transfec-
tion, we observed that IMR90 siDNMT1/p14ARF cells
proliferated to the same rate of control cells (Figure 4C,
top panel). Moreover, 72 hours post-transfection cyto-
fluorimetric analyses showed a cell cycle progression
similar to that of control cells (Figure 4C, bottom panels).
Altogether, these results suggest that p14ARF is involved
in the response of IMR90 cells to DNMT1 knockdown.
DNMT1 depletion induces a global DNA demethylation
One potential role of the G1-arrest triggered by
DNMT1 depletion is to protect the genome from global
loss of DNA methylation. DNMT1 has been shown to
be loaded on chromatin throughout G2 and M [17],
however, it mainly functions as a maintenance DNA-
methyltransferase by methylating specific cytosines dur-
ing DNA replication [18-21]. Thus, the effects of its
absence on DNA methylation can be revealed in active
proliferating cells. To this aim we investigated if transi-
ent DNMT1 silencing resulted in DNA demethylation in
HCT-siDNMT1 cells that were not G1-arrested. To this
aim anti-5-methylcytosine antibody was used to com-
pare the DNA methylation status of HCT-siDNMT1 to
HCT116 control cells. Cells were stained with the “cap-
ture antibody” (primary) and with the “detection anti-
body” (secondary) subsequently, and DNA methylation
was quantified through an ELISA-like reaction. By this
assay the DNA of HCT-siDNMT1 cells resulted globally
demethylated (table 1) in comparison to control cells
(1,2% DNA methylation vs. 5,65%). By this method,
however, we were unable to see differences in DNA
methylation between IMR90-siDNMT1/p53, IMR90-
siDNMT1/p14, both not G1-arrested (data not shown),
and IMR90 control cells. Therefore, we determine DNA
methylation by Slot-Blot Analysis using a mouse mono-
clonal antibody to detect 5-methylcytosine (5-MeC)
levels. By this approach we observed reduction of DNA
methylation in IMR90-siDNMT1/p53 and IMR90-
Figure 3 DNMT1 transient downregulation does not induce DNA damage. Immunofluorescence analysis against gH2A.X revealed that
DNMT1 silencing did not induce gH2A.X positive foci formation in both IMR90 and HCT116 cells. Cells treated with Adriamicyn were used as a
positive control.
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siDNMT1/p14ARF relative to IMR90 control cells (Fig-
ure 5). These results suggest that DNA demethylation
can occur in DNMT1-depleted HCT116 and IMR90
cells when they do not arrest in G1
IMR90 and HCT116 cells become aneuploid if they do not
arrest in G1 following DNMT1 depletion
In the last few years it has been hypothesized that DNA
hypomethylation in cancer is strictly correlated with the
observed genomic instability [22] and in particular with
aneuploidy [23-26]. To ascertain if DNA hypomethyla-
tion might be implicated in the generation of
chromosomal instability, at least in the cells analyzed
here, we investigated if transient DNMT1 post-transcrip-
tional silencing could induce aneuploidy in diploid cells
that did not arrest in G1. To this aim we did cytogenetic
analyses in IMR90 and HCT116 cells treated for 72
hours with siDNMT1. The mitotic index of HCT-
siDNMT1 and of HCT116 control cells was the same
(12%), and the observed mitotic cells (n = 35) were
aneuploid (62%, mainly hypodiploid) (Figure 5A, panel
on the left). On the contrary, despite of the long colce-
mid treatment IMR90-siDNMT1 cells showed very few
mitotic cells (Mitotic index 0,3% vs 3% of IMR90 con-
trol cells) because of G1 arrest, and the majority of
them were hyperdiploid (Figure 6A, panel on the right).
Thus, the significance of the difference in ploidy
between HCT116 and IMR90 cells (hypodiploidy vs
hyperdiploidy) has to be considered cautiously.
To ascertain that lack of G1 arrest in presence of
decreased DNMT1, as observed in HCT-siDNMT1 cells,
contributed to aneuploidy we did a cytogenetic analysis
of siDNMT1/p53 and siDNMT1/p14ARF IMR90 cells
that despite DNMT1 depletion proliferated incorrectly.
Figure 4 p14ARF depletion abrogates G1 arrest after DNMT1 depletion. A) Real time RT-PCR revealed transcript levels of DNMT1 and
p14ARF in siDNMT1 and siDNMT1/p14ARF IMR90 cells in comparison with control cells. B) Real time RT-PCR revealed that p21waf1-Cip1 was not
transactivated in absence of p14ARF after DNMT1-depletion in IMR90 cells at 72 hours. C) Top panel: histogram showing proliferation of IMR90
siDNMT1/p14ARF cells in comparison to control cells. Bottom panels: cytofluorimetric profiles of IMR90-siDNMT1/p14 cells stained with
Propidium Iodide (PI) as indicator of DNA content, which revealed no significative difference on cell cycle progression in comparison to control
cells. IMR90-sip14 cells were used also as a control.
Table 1 DNA methylation status after DNMT1 silencing in
HCT116
Sample % Methylated DNA
HCT116 ctrl 5,9% ± 0,4
HCT-siDNMT1 1,95% ± 1,06
DNA extracted from cells was treated with anti-5-methylcytosine antibody,
stained with the “capture antibody” and the “detection antibody” and then
quantified by an EliSa-like reaction. DNA extracted from HCT-siDNMT1 cells
appeared demethylated in comparison to that extracted from HCT116 cells.
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This experiment showed that the number of IMR90-
siDNMT1/p53 mitotic cells (mitotic index 3%) was simi-
lar to that of control IMR90 cells and likely reflects the
ability to bypass the G1 arrest. Most importantly the
majority (70%) of the observed mitosis (n = 35) were
hypodiploid (Figure 6B) as shown by HCT-siDNMT1
cells that did not arrest in G1 (Figure 6A). IMR90-
siDNMT1/p14ARF showed the same mitotic index of
control cells and were mainly hypodiploid (Figure 6B).
These results show that in absence of the G1 arrest pro-
voked by DNMT1 depletion the analyzed cells acquired
aneuploidy. This last finding suggests that the G1 arrest
is induced to protect cells from aneuploidy likely due to
DNA hypomethylation that would occur after DNMT1
depletion.
Discussion
DNA methylation, histone methylation and deacetyla-
tion combine to bring about DNA hypercondensation
typical of centromeric and pericentromeric chromatin
[27,28]. DNMT1 downregulation might alter this combi-
nation leading to chromatin decondensation that could
determine chromosomes missegregation. Imbalance in
cytosine methylation (hypomethylation) and deregula-
tion of DNA methyl-transferases, in particular DNMT1,
are recurrent in human sporadic cancers and it seems
that they could be involved in the acquisition of chro-
mosomal instability [10]. Deregulated expression of
DNMT1 is frequently observed in human tumors
[12,29-31] however its correlation with cancer progres-
sion is still object of investigation.
By using two different cell types, primary human fibro-
blasts (IMR90) and stable near-diploid tumor cells
(HCT116), we determined that DNMT1 transient deple-
tion had different outcomes related to the genetic context
of the cell. We observed that the transient DNMT1 post-
transcriptional silencing promptly induced G1 arrest in
human fibroblasts, but only a slight decrease of cell pro-
liferation in HCT116 cells. As a consequence of the pro-
liferation arrest mediated by DNMT1 transient depletion
IMR90 fibroblasts showed very few mitotic cells. These
findings suggest the existence in IMR90 fibroblasts of a
p53 controlled cellular pathway that following DNMT1
depletion activates a putative G1-checkpoint that is not
properly working in tumor HCT116 cells. The p53 invol-
vement in response to DNMT1 depletion was further
suggested by the finding that double silenced IMR90 cells
(IMR90-siDMT1/p53) did not arrest anymore. Our
observation that IMR90 cells restarted proliferation after
144 hours from siDNMT1 transfection, and that the p53
amount decreased, are additional evidence of the exis-
tence of a p53 controlled checkpoint, that is activated in
response to DNMT1 depletion. The absence of gH2AX
positive foci rules out that the DNMT1 depletion acti-
vates the classic p53 pathway induced by DNA damage.
This is confirmed by the fact that HCT116 cells
responded correctly to the presence of DNA damage by
increasing p53 protein levels, but were unable to halt cel-
lular proliferation in response to transient DNMT1
depletion. Altogether, these results suggest that in
HCT116 cells is missing some factor necessary to activate
the pathway induced by DNMT1-depletion.
The fact that IMR90-siDNMT1/p14ARF cells did not
arrest in G1 indicates that p14ARF is necessary for the
cell cycle arrest in IMR90 cells, and also suggests
p14ARF as the specific intermediate necessary to acti-
vate/stabilize p53 in response to DNMT1 depletion.
Thus, the presence of dysfunctional p14ARF in HCT116
cells [13] might explain why these cells cannot properly
respond to DNMT1 depletion resulting then in
Figure 5 DNA methylation status in double silenced IMR90 cells. On the left is shown the Slot-blot analysis of 5-methylcytosine (5-MeC)
antibody. DNA samples of control, siDNMT1/p14 and siDNMT1/p53 IMR90 cells were spotted onto Hybond-N membrane and blotted with 5-
MeC antibody. Spotted DNA quantity was revealed by methylene blue staining. On the right is shown the graph illustrating differences in 5-MeC
quantity between control, siDNMT1/p14 and siDNMT1/p53 IMR90 cells. Data are expressed related to control cells following DNA normalization
with methylene blue.
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unscheduled progression from G1 to S phase of the cell
cycle.
DNMT1 silencing and lack of G1 arrest resulted in the
induction of aneuploidy in both cell lines analyzed.
Recently, it has been proposed that aneuploidy found in
different human tumors is caused directly by hypo-
methylation of specific chromosomal regions that are
usually hypermethylated, such as pericentromeric
regions, whose function is correlated with chromosome
structure (centromere formation) and faithful segrega-
tion [23-26]. The incorrect cell cycle progression of
HCT116 cells was correlated with a reduction of DNA
methylation degree and we hypothesize that DNA hypo-
methylation could be the cause of aneuploidy in these
cells.
Finally, increase in the number of IMR90 aneuploidy
cells was seen only after incorrect G1/S progression
induced by p53 and p14ARF post-transcriptional silen-
cing. This last finding again highlights the existence of a
pathway p14ARF/p53 controlled able to preserve normal
cells from incorrect DNA methylation status affected by
DNMT1 lack.
Conclusions
Altogether our results suggest for the first time the exis-
tence of a checkpoint functioning in G1 that protect
cells from DNA hypomethylation occurrence that in
turn causes aneuploidy. Primary human cells (IMR90)
perceive DNMT1 absence that might lead to hypo-
methylation, as a stress signal and thus, activate a path-
way p14ARF/p53 controlled inducing G1 arrest. When
this pathway is not working like in HCT116 tumor cells
lacking p14ARF or it is abrogated by silencing p14ARF
or p53, cells progress incorrectly in the cell cycle with
altered DNA methylation pattern (hypomethylation),
that might affects also the right chromosomal segrega-
tion thus, resulting in aneuploidy (Figure 7). The
mechanism by which hypomethylation can influence
correct chromosome segregation has to be further stu-
died. Nevertheless, we hypothesize that DNMT1 lack
might alter the methylation pattern of pericentromeric
chromosomal regions. Hypomethylation may cause
Figure 7 Speculative model of a putative pathway induced by
DNMT1 depletion. Schematic shows the effects of DNMT1
depletion perceived by a “sensor” factor (p14ARF) that activates a
pathway p53-controlled triggering G1 arrest in normal cells. If p53
or p14ARF are absent or not working properly, cells are unable to
sense DNMT1 depletion and, thus, progress in the cell cycle
incorrectly with wrong DNA methylation patterns triggering
aneuploidy.
Figure 6 Cytogenetic effects of transient DNMT1
downregulation. A) Histograms showing percentages of both
aneuploid and diploid metaphases of IMR90-siDNMT1 and HCT-
siDNMT1. 35 metaphases were scored for all cell types except that
for IMR90-siDNMT1 (n = 11). B) Histograms showing the presence of
high number of aneuploid metaphases (mainly hypodiploid) in
IMR90-siDNMT1/p53 and -siDNMT1/p14ARF cells at 72 h in
comparison to control cells. IMR90 -sip53 and -sip14ARF cells were
used as a negative control.
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chromatin decondensation and in this way to compro-
mise the correct centromere formation, kinethocore
assembly, spindle fibres attachment and chromosome
segregation.
Methods
Cells and cell culture
Human primary fibroblasts (IMR90 passage 12, ATCC)
were cultured in EMEM supplemented with: 10% FBS
(GIBCO, Life Technologies), 100 units/ml penicillin and
0,1 mg/ml streptomycin (GIBCO, Life Technologies), 1%
NEAA (GIBCO, Life Technologies), the human colon
cancer cell line HCT116 [32] was cultured in DMEM
supplemented with: 10% FBS, 100 units/ml penicillin
and 0,1 mg/ml streptomycin. Cells were cultured in a
humidified atmosphere of 4% CO2 in air at 37°C. For
siRNAs transfection 1, 5 × 105 IMR90 cells and 2, 5 ×
105 HCT116 cells were plated in 6-well dishes and incu-
bated at 37°C. Specific siRNAs duplex were mixed with
Lipofectamine2000 Reagent (Invitrogen, Life Technolo-
gies), according to manufacturer’s recommendation and
added to the cells. After 6 hours at 37°C, the transfec-
tion medium was replaced with fresh medium. To
silence genes of interest post-transcriptionally, cells were
transfected with siRNAs targeting DNMT1 (siDNMT1:
5’- AUU ACG UAA AGA AGA AUU A dTdT-3’) [14]
at final concentrations of 60, 80 and 100 nM, siRNAs
targeting TP53 (si p53: 5’-GCA UGA ACC GGA GGC
CCC AUtt-3’) [33] and p14ARF (sip14: 5’-GAA GAU
CAG GUC AUG AUG Att-3’) [34] at a final concentra-
tion of 60 nM. All siRNAs were synthesized by Euro-
fins-MWG.
Real time RT-PCR
Primers to be used in Real time RT-PCR experiments
were designed with Primer Express software (Applied
Biosystems, Life Technologies) choosing amplicons of
approximately 70-100 bp. The selected sequences were
tested against public databases (BLAST) to confirm the
identity of the genes. Total RNA was extracted from
cells by using the RNAeasy mini kit (GE) or the “All
prep DNA/RNA kit” (Qiagen) according to the manu-
facture’s instruction. RNA was reverse-transcribed in a
final volume of 100 μL using the High Capacity c-DNA
Archive kit (Applied Biosystems, Life Technologies) for
10 minutes at 25°C and 2 hours at 37°C. For each sam-
ple 2 μL of cDNA, corresponding to approximately 100
nag of reverse transcribed RNA, was analyzed by Real
time RT-PCR (95°C for 15 sec, 60°C for 60 sec repeated
for 40 cycles), in quadruplicate, using the ABI PRISM
7300 instrument (Applied Biosystems). Real time RT-
PCR was done in a final volume of 20 μl comprising 1x
Master Mix SYBR Green (Applied Biosystems, Life
Technologies) and 0, 3 μM of forward and reverse
primers for: DNMT1 (Fw: 5’-GCACCTCATTTGCC-
GAATACA-3’; Rev: 5’-TCTCCTGCATCAGCC-
CAAATA-3’), TP53 (Fw: 5’-TTCGACATAGTGT
GGTGGTGC-3’; Rev: 5’- AGTCAGAGCCAACCT-
CAGGC-3’), p21WAF1-Cip1 (Fw: 5’-CTGGAGACTCT-
CAGGGTCGA-3’, Rev: 5’-CG GATTAGGGCTTCC
TCTTG-3’), p14ARF (Fw: 5’- TGA TGCTACTGAG-
GAGCCAGC-3’, Rev: 5’-AGGGC C TTTCCTACCT
GGCTC-3’), GAPDH (Fw: 5’-CTCATG ACCACAGTC-
CATGCC-3’, Rev: 5’-GCCATCCACA GTCTTCTGG
GT-3’). Data were analyzed by averaging quadruplicates
Ct (cycle threshold). Levels of RNA expression were
determined by using the SDS software version (Applied
Biosystems, Life Technologies) according to the 2-ΔΔct
method. Levels of RNA expression of selected genes
were normalized to the internal control GAPDH.
Western Blotting
Protein concentration was measured using the Bio-Rad
Protein Assay (Bio-Rad Laboratories). Proteins (40 μg)
were separated by 10% SDS-PAGE containing 0,1% SDS
and transferred to Hybond-C nitrocellulose membranes
(Amersham Life Science) by electro-blotting. The mem-
branes were sequentially incubated with goat anti-
DNMT1, rabbit anti-p21WAF1-Cip1, rabbit anti-pRb
(Santa Cruz, CA), mouse anti-p53 (Abcam, UK) as pri-
mary antibodies, and HRP-conjugated mouse, rabbit
(Abcam, UK) and goat (Santa Cruz, CA) Gig as second-
ary antibodies. The target protein was detected with
enhanced chemiluminescence Western blotting detec-
tion reagents (Pierce, Thermo Scientific). We used also
mouse anti-b-tubulin (SIGMA, Italy) as internal control
of loading. Membranes were stained by Ponca-Red to
confirm equivalent loading of total protein in all lanes.
Cell cycle analysis
Asynchronously growing cells were treated with 80 nM
siDNMT1 alone or together with 60 nM sip53 for 72
hours and released into complete medium with Bromo-
deoxiUridine (BrdU, SIGMA, Italy) 0, 2 μg/ml for one
hour. DNA content was determined using Propidium
Iodide (PI, SIGMA, Italy) staining by treating cells with
PBS solution containing 4 μg/ml of PI and 40 μg/ml
RNase. Analysis of BrdU labelled cells was conducted as
described previously [5] and samples were analyzed on a
FACSCanto (Becton Dickinson). Analysis of IMR90-
siDNMT1/p14ARF cell cycle was made by PI staining of
DNA content. Experiments were repeated at least twice,
10000 events were analyzed by FACSDiva software.
Cytogenetics analysis
Cells were seeded onto glass cover slides 24 hours
before the analysis. They were then, treated with 0,2 μg/
ml colcemid (Demecolcine, SIGMA, Italy) for three
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(HCT116) four (IMR90) or eight (IMR90-siDNMT1)
hours. Cell were swollen in 75 mM KCl at 37°C, fixed
with methanol/acetic acid (3:1 v/v) The cover slides
were then air-dried and stained with 3% GIEMSA in
phosphate-buffered saline for 10 minutes. Chromosome
metaphases were evaluated using a Zeiss Axioskop
microscope under a 63× objective. The analysis was
repeated three times for each cell types.
Immunofluorescence microscopy
Phosphorylated H2A.X immunostaining: IMR90 and
HCT116 were grown on glass coverslips after siRNAs
transfection. Cells on coverslips were fixed with cold
methanol (-20°C), permeabilized with 0.01% Triton ×
(Sigma, Italy) and blocked with 0.1% BSA, both at room
temperature. Then, coverslips were incubated with
phosphorylated H2A.X rabbit polyclonal antibody (1:100
in PBS-BSA 0.1%, Upstate) overnight at 4°C, washed in
PBS and incubated with a FITC-conjugated rabbit anti-
mouse (Sigma, Italy) diluted 1:100 in PBS-BSA 0,1%) for
1 hour at 37°C. Nuclei were visualized with 1 μg/ml of
4’,6-Diamidino-2-phenylindole (DAPI) and examined on
a Zeiss Axioskop microscope (Zeiss, Germany) equipped
for fluorescence under a 63× objective. Images were
captured with a CCD digital camera (AxioCam, Zeiss).
Global DNA methylation analysis
“Methylamp Global DNA methylation quantification kit”
(Epigentek, USA) was used to quantify global DNA
methylation. 200 ng of genomic DNA extracted from cell
samples was immobilized in the strip well specifically
treated to have high affinity to DNA for 2 hours at 37°C.
The methylated fraction of DNA can be recognized by
sequential incubation with 5-methylcytosine antibody for
45 minutes at 37°C, and with secondary antibody for 60
minutes at room temperature. A colorimetric reaction
allowed methylated DNA quantification at 450 nM with
microplate reader. A methylated DNA was used as posi-
tive control. The analysis was repeated twice.
Slot Blot analysis
The DNA-slot blot analysis of 5-Methylcytosine was
performed as described [35] with the following modifi-
cations. Purified DNA (100 μg/25 μL) from control,
siDNMT1/p14ARF and siDNMT1/p53 IMR90 cells, was
denatured at 100°C for 5 min and applied onto Hybond-
N membrane (RPN203N, Amersham) using the Hybri-
slot Manifold Apparatus (Whatman Biometra, Germany)
under vacuum for 3 min. DNA was fixed to the mem-
brane by exposing to UV light (90,000 μjoules/cm2) for
45 seconds using the Hoefer UVC 50 Crossliker (Amer-
sham Biosciences). Samples were then treated with
TBST, (0.05% Tween20), 5% w/v no-fat dry milk block-
ing buffer for 1 hour at RT and incubated with 5-
Methylcytosine Monoclonal Antibody (1:500, cloneD33,
Epigentek USA) in TBST (0.05% Tween20) 5% w/v no-
fat dry milk blocking buffer for 1 hour at RT. The mem-
brane was then washed with TBST (0.05% Tween20), 3
times for 10 minutes each, incubated with HRP conju-
gated secondary antibody anti-mouse (1:2000) (Abcam,
UK) in blocking buffer for 1 hour at RT, washed again
with TBST (0.05% Tween20), 3 times for 10 minutes
each and once in double distilled water for 5 minutes,
then developed by enhanced chemiluminescence detec-
tion reagents (Pierce Thermo Scientific) and image
acquired with Chemidoc XSR Imaging System (BioRad).
Spotted DNA quantity was detected by 0.02% w/v
methylene blue in 0.3 M sodium acetate (pH5.2) fol-
lowed by washing in double distilled water to reduce
background noise. The relative 5 MeC Optical density
(OD) value was calculated with Quantity One 4.6.7 soft-
ware relative to DNA amount loaded and normalized to
wild type sample.
Additional material
Additional file 1: Densitometric analysis of Western blot in Figure
1D. Graph illustrating differences in Dnmt1 protein amount between
control and siDNMT1 IMR90 cells, and between control and siDNMT1
HCT116 cells. Data are related to control cells following normalization
with b-tubulin.
Additional file 2: Densitometric analysis of Western blot in Figure
2B. Graph illustrating differences in p21waf1 protein between control and
siDNMT1 IMR90cells. Data are related to control cells following
normalization with b-tubulin.
Additional file 3: Densitometric analysis of Western blot in Figure
2C. Graph illustrating differences in p53 protein level between control
and siDNMT1 IMR90 cells at 72 h-144 h as well between control and
siDNMT1 HCT116 cells at 72 h all treated with adriamicyn. Data are
related to control cells following normalization with b-tubulin.
Additional file 4: Densitometric analysis of Western blot in Figure
2E. Graph illustrating differences in DNMT1, p53 and p21waf1 protein
levels between control and siDNMT1/p53 MR90 cells. Data are related to
control cells following normalization with b-tubulin.
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